Tim Rhodes
Tim Rhodes
London School of Hygiene and Tropical Medicibe / University of New South Wales
Verified email at - Homepage
Cited by
Cited by
The ‘risk environment’: a framework for understanding and reducing drug-related harm
T Rhodes
International journal of drug policy 13 (2), 85-94, 2002
The social structural production of HIV risk among injecting drug users
T Rhodes, M Singer, P Bourgois, SR Friedman, SA Strathdee
Social science & medicine 61 (5), 1026-1044, 2005
Risk environments and drug harms: a social science for harm reduction approach
T Rhodes
International journal of drug policy 20 (3), 193-201, 2009
HIV and risk environment for injecting drug users: the past, present, and future
SA Strathdee, TB Hallett, N Bobrova, T Rhodes, R Booth, R Abdool, ...
The Lancet 376 (9737), 268-284, 2010
Global overview of injecting drug use and HIV infection among injecting drug users
C Aceijas, GV Stimson, M Hickman, T Rhodes
Aids 18 (17), 2295-2303, 2004
Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed
L Degenhardt, B Mathers, P Vickerman, T Rhodes, C Latkin, M Hickman
The Lancet 376 (9737), 285-301, 2010
Global estimates of prevalence of HCV infection among injecting drug users
C Aceijas, T Rhodes
International journal of drug policy 18 (5), 352-358, 2007
Risk theory in epidemic times: sex, drugs and the social organisation of ‘risk behaviour’
T Rhodes
Sociology of Health & Illness 19 (2), 208-227, 1997
Interventions to prevent HIV and hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness
GJ MacArthur, E van Velzen, N Palmateer, J Kimber, A Pharris, V Hope, ...
International Journal of Drug Policy 25 (1), 34-52, 2014
The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality
TH Karlsen, N Sheron, S Zelber-Sagi, P Carrieri, G Dusheiko, E Bugianesi, ...
The Lancet 399 (10319), 61-116, 2022
Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a …
N Palmateer, J Kimber, M Hickman, S Hutchinson, T Rhodes, D Goldberg
Addiction 105 (5), 844-859, 2010
Transition and the HIV risk environment
T Rhodes, M Simic
Bmj 331 (7510), 220-223, 2005
Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factors
M Harris, T Rhodes
Harm reduction journal 10, 1-11, 2013
Structural violence and structural vulnerability within the risk environment: theoretical and methodological perspectives for a social epidemiology of HIV risk among injection …
T Rhodes, K Wagner, SA Strathdee, K Shannon, P Davidson, P Bourgois
Rethinking social epidemiology: Towards a science of change, 205-230, 2012
HIV infection associated with drug injecting in the newly independent states, eastern Europe: the social and economic context of epidemics
T Rhodes, A Ball, GV Stimson, Kobyshcha, C Fitch, V Pokrovsky, Marina, ...
Addiction 94 (9), 1323-1336, 1999
Public injecting and the need for ‘safer environment interventions’ in the reduction of drug‐related harm
T Rhodes, J Kimber, W Small, J Fitzgerald, T Kerr, M Hickman, ...
Addiction 101 (10), 1384-1393, 2006
Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliatti City, Russian Federation: a qualitative study of micro risk environment
T Rhodes, L Mikhailova, A Sarang, CM Lowndes, A Rylkov, M Khutorskoy, ...
Social science & medicine 57 (1), 39-54, 2003
Public injection settings in Vancouver: physical environment, social context and risk
W Small, T Rhodes, E Wood, T Kerr
International Journal of Drug Policy 18 (1), 27-36, 2007
Police violence and sexual risk among female and transvestite sex workers in Serbia: qualitative study
T Rhodes, M Simić, S Baroš, L Platt, B Žikić
Bmj 337, 2008
Impact of opioid substitution therapy on antiretroviral therapy outcomes: a systematic review and meta-analysis
AJ Low, G Mburu, NJ Welton, MT May, CF Davies, C French, KM Turner, ...
Clinical Infectious Diseases 63 (8), 1094-1104, 2016
The system can't perform the operation now. Try again later.
Articles 1–20